Maturity-onset diabetes on the young (MODY), MODY genes and non-insulin-dependent diabetes mellitus

Diabetes and Metabolism

Volumn 23, Issue SUPPL. 2, 1997, Pages 34-37

  Velho, G ^a   Froguel, Ph ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

glucokinase; hepatic nuclear factor; hyperglycaemia; maturity onset diabetes of the young; non insulin dependent diabetes mellitus

Indexed keywords

GLUCOKINASE; GLYCOGEN;

CHROMOSOME 20Q; CONFERENCE PAPER; GLUCONEOGENESIS; HUMAN; HUMAN GENETICS; INSULIN RELEASE; MATURITY; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION;

AGE OF ONSET; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; DIABETES MELLITUS, TYPE 2; DNA-BINDING PROTEINS; FRANCE; GLUCOKINASE; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PREVALENCE; TRANSCRIPTION FACTORS;

EID: 0030891555     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (42)

1. Steiner DF, Tager HS, Chan SJ, Nanjo K, Sanke T, Rubenstein AH. Lessons learned from molecular biology of insulin-gene mutations. Diabetes Care, 1990, 13, 600-609.
2. Taylor SI. Molecular mechanisms of insulin resistance : lessons from patients with mutations in the insulin-receptor gene. Diabetes, 1992, 41, 1473-1490.
3. Van den Ouweland JMW, Lemkes HHPJ, Ruitenbeek W et al. Mutation in mitochondrial tNRA Leu(UUR) gene in a large pedigree with maternally transmitted type II diabetes and deafness. Nature Genetics, 1992, 1, 368-371.
4. Froguel P, Zouali H, Vionnet N et al. Familial hyperglycemia due to mutations in glucokinase : definition of a subtype of diabetes mellitus. N Engl J Med, 1993, 328, 697-702.
5. Froguel P, Velho G. Maturity onset diabetes of the young. Curr Opin Pediatr, 1994, 6, 482-485.
6. Bell GI, Xiang KS, Newman MV et al. Gene for non-insulin-dependent diabetes mellitus (maturity onset diabetes of the young subtype) is linked to DNA polymorphism on chromosome 20q. Proc Natl Acad Sci USA, 1991, 88, 1484-1488.
7. Yamagata K, Furuta H, Oda O et al. Mutations in the hepatocyte nuclear factor 4 alpha gene in maturity-onset diabetes of the young (MODY1). Nature, 1996, 384, 458-460.
8. Froguel P, Vaxillaire M, Sun F et al. The glucokinase locus on chromosome 7p is closely linked to early onset non-insulin-dependent diabetes mellitus. Nature, 1992, 356, 162-164.
9. Velho G, Blanché H, Vaxillaire et al. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia, 1997, 40 (in press).
10. Vaxillaire M, Boccio V, Philippi A et al. A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nature Genetics, 1995, 9, 418-423.
11. Menzel S, Yamagata K, Trabb JB et al. Localization of MODY3 to a 5-cM region of human chromosome 12. Diabetes, 1995, 44, 1408-1413.
12. Yamagata K, Oda N, Kaisaki PJ et al. Mutations in the hepatocyte nuclear factor 1 alpha gene in maturity-onset diabetes of the young (MODY3). Nature, 1996, 384, 455-458.
13. Fajans SS. Scope and heterogeneous nature of MODY. Diabetes Care, 1990, 13, 49-64.
14. Ledermann HM. Is maturity onset diabetes at young age (MODY) more common in Europe than previously assumed ? Lancet, 1995, 345, 648 (Letter).
15. Matschinsky FM. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes, 1996, 45, 223-241.
16. Gidh-Jain M, Takeda J, Xu LZ et al. Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity : implications for structure/function relationships. Proc Natl Acad Sci USA, 1993, 90, 1932-1936.
17. Stuns J, Kurland IJ, Byrne MM et al. Compensation in pancreatic beta-cell function in subjects with glucokinase mutations. Diabetes, 1994, 43, 718-723.
18. Velho G, Froguel P, Clément K et al. Primary pancreatic beta-cell secretory defect caused by mutations in the glucokinase in kindreds of maturity onset diabetes of the young. Lancet, 1992, 340, 444-448.
19. Byrne MM, Sturis J, Clément K et al. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest, 1994, 93, 1120-1130.
20. Pueyo ME, Clement K, Vaxillaire M et al. Arginine-induced insulin release in glucokinase-deficient subjects. Diabetes Care, 1994, 17, 1015-1021.
21. Velho G, Petersen KF, Perseghin G et al. Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J Clin Invest, 1996, 98, 1755-1761.
22. Clément K, Pucyo ME, Vaxillaire M et al. Assessment of insulin sensitivity in glucokinase-deficient subjects. Diabetologia, 1996, 39, 82-90.
23. Efrat S, Leiser M, Wu YJ et al. Rybozyme-mediated attenuation of pancreatic beta-cell glucokinase expression in transgenic mice results in impaired glucose-induced insulin secretion. Proc Natl Acad Sci USA, 1994, 91, 2051-2055.
24. Grupe A, Hultgren B, Ryan A, Ma YH, Bauer M, Stewart TA. Transgenic knockouts reveal a critical requirement for pancreatic beta cell glucokinase in maintaining glucose homeostasis. Cell, 1995, 83, 69-78.
25. Bali D, Svetlanov A, Lee HW et al. Animal model for maturity-onset diabetes of the young generated by disruption of the mouse glucokinase gene. J Biol Chem, 1995, 270, 21464-21467.
26. Vaxillaire M, Rouard M, Yamagata K et al. Identification of nine novel mutations in the hepatocyte nuclear factor 1 alpha gene associated with maturity-onset diabetes of the young (MODY3). Hum Mol Genet, 1997 (in press).
27. Velho G, Pueyo ME, Vaxillaire M, Clément K, Frogucl P, Robert J-J. Assessment of insulin secretion and sensitivity in carriers of the diabetes susceptibility haplotype at the MODY-3 locus [Abstract]. Diabetes, 1996, 45 (suppl. 2), 297A.
28. Byrne MM, Sturis J, Menzel S et al. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes mellitus susceptibility gene MODY on chromosome 12. Diabetes, 1996, 45, 1503-1510.
29. Velho G, Vaxillaire M, Boccio V, Charpentier G, Froguel P. Diabetes complications in NIDDM kindreds linked to the MODY-3 locus on chromosome 12q. Diabetes Care, 1996, 19, 915-919.
30. Fajans SS, Bell GI, Bowden DW, Halter JB, Polonsky KS. Maturityonset diabetes of the young. Life Science, 1994, 55, 413-422.
31. Herman WH, Fajans SS, Ortiz FJ et al. Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree. Diabetes, 1994, 43, 40-46.
32. Byme MM, Sturis J, Fajans SS et al. Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes, 1995, 44, 699-704.
33. Yki-Jarvinen H. Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia, 1995, 38, 1378-1388.
34. Polonsky KS, Sturis J, Bell GI. Non-insulin-dcpendent diabetes mellitus-a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med, 1996, 334, 777-783.
35. Permutt MA, Chiu KC, Tanizawa Y. Glucokinase and NIDDM : a candidate gene that paid off. Diabetes, 1992, 41, 1367-1372.
36. Zouali H, Vaxillaire M, Lesagc S et al. Linkage analysis and molecular scanning of the glucokinase gene in NIDDM families. Diabetes, 1993, 42, 1238-1245.
37. Shelton KD, Franklin AJ, Khoor A, Beechem J, Magnuson MA. Multiple elements in the upstream glucokinase promoter contribute to transcriptionin insulinoma cells. Mol Cell Biol, 1992, 12, 4578-4589.
38. Stone LM, Kahn SE, Fujimoto WY, Deeb SS, Porte D, Jr. A variant at position -30 of the β-cell glucokinase gene promoter is associated with reduced β-cell function in middle-aged Japanese-American men. Diabetes, 1996, 45, 422-428.
39. Lesage S, Hani EH, Philippi A et al. Linkage analyses of the MODY3 locus on chromosome 12q with late-onset NIDDM. Diabetes, 1995, 44, 1243-1247.
40. Mahtani MM, Widén E, Lehto M et al. Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nature Genet, 1996, 14, 90-94.
41. Vaxillaire M, Butel MO, Zouali H et al. Linkage studies give evidence for genetic heterogeneity in type 2 diabetes mellitus. (Abstract). Diabetologia, 1992, 35, A62.
42. Baroni MG, Alcolado JC, Needham EWA, Pozzilli P, Stocks J ; Galton DJ. Sib-pair analysis of adenosine deaminase locus in NIDDM. Diabetes, 1992, 41, 1640-1643.